Sven Erickson
Impact in
- Immunology top 5%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
Papers in
- Oncology 9
- Cancer-related Molecular Pathways 7
- Cytokine Signaling Pathways and Interactions 4
-
- interferon and immune responses 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Co-authors
- Dan Grandér (10 shared papers)Stefan Einhorn (10 shared papers)Olle Sangfelt (8 shared papers)Juan Castro (6 shared papers)Lena Thyrell (2 shared papers)Boris Zhivotovsky (1 shared paper)Mats Heyman (2 shared papers)T Heiden (1 shared paper)
- Journals
- Oncogene (4 papers)Blood (2 papers)European Journal of Biochemistry (1 paper)British Journal of Pharmacology (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Sven Erickson
12 papers receiving 920 citations
Peers
Comparison fields: 5 of 80
- Immunology 408
- Oncology 399
- Toxicology 27
- Hepatology 39
- Cancer Research 74
Countries citing papers authored by Sven Erickson
This map shows the geographic impact of Sven Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Erickson more than expected).
Fields of papers citing papers by Sven Erickson
This network shows the impact of papers produced by Sven Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Erickson. The network helps show where Sven Erickson may publish in the future.
Co-authors
The 21 scholars most cited alongside Sven Erickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 190 | |
| 2 | 1999 | 123 | |
| 3 | Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. | 1997 | 111 |
| 4 | 2003 | 100 | |
| 5 | 1997 | 100 | |
| 6 | 1998 | 97 | |
| 7 | 2000 | 85 | |
| 8 | 1997 | 65 | |
| 9 | Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins. | 1999 | 40 |
| 10 | 2002 | 17 | |
| 11 | 2003 | 4 | |
| 12 | 2000 | 3 |
About Sven Erickson
Sven Erickson is a scholar working on Oncology, Immunology, Molecular Biology, Physiology and Epidemiology, having authored 12 papers that have together received 935 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), interferon and immune responses (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Telomeres, Telomerase, and Senescence (3 papers), Cell death mechanisms and regulation (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Immunology (408 citations), Oncology (399 citations), Toxicology (27 citations), Hepatology (39 citations) and Cancer Research (74 citations). Sven Erickson has collaborated with scholars based in Sweden and United States. Frequent co-authors include Dan Grandér, Stefan Einhorn, Olle Sangfelt, Juan Castro, Lena Thyrell, Boris Zhivotovsky, Mats Heyman, T Heiden, Anna Gustafsson and Thomas Heiden. Their work appears in journals such as Oncogene, Blood, European Journal of Biochemistry, British Journal of Pharmacology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.